mTOR in acquired epilepsy

mTOR signaling is enhanced in diverse epilepsy models. Phosporylated S6 is a marker of mTOR pathway activation (through immunostaining). Rapamycin prevents hippocampal granule cell mossy fiber sprouting, dendritic change, regulate ion channel expression, and block increases in spotaneous excitatory current frequency [1] A limitations of rapamycin as a treatment in epilepsy is that also it inhibits interneuron sprouting (parvalbumin and somatostatin-expressing interneurons [1]. So mTOR might cause anti and pro-epileptogenic effects.

[1]
M. Wong, A. Bordey, and S. C. Danzer, “mTOR in acquired and genetic models of epilepsy,” in Jasper’s basic mechanisms of the epilepsies, J. L. Noebels, M. Avoli, M. A. Rogawski, A. Vezzani, A. V. Delgado-Escueta, J. L. Noebels, M. Avoli, M. A. Rogawski, A. Vezzani, and A. V. Delgado-Escueta, Eds., Oxford University Press, 2024, p. 0. doi: 10.1093/med/9780197549469.003.0004. Available: https://doi.org/10.1093/med/9780197549469.003.0004. [Accessed: Nov. 04, 2025]